Jan 8, 2026 08:11AM
Dec 31, 2025 06:37AM
Dec 11, 2025 07:32AM
Dec 3, 2025 06:41AM
Nov 11, 2025 04:26AM
Sep 2, 2025 06:19AM
Jul 11, 2025 04:15PM InflaRx receives NASDAQ deficiency notice for minimum bid price
May 29, 2025 03:46AM
May 28, 2025 10:35AM
May 28, 2025 04:55AM
May 13, 2025 04:37PM
Apr 29, 2025 06:32AM
Mar 26, 2025 06:57AM
Feb 13, 2025 04:01PM InflaRx (IFRX) Announces Public Offering of Ordinary Shares and Pre-Funded Warrants
Jan 16, 2025 06:54AM
Jan 15, 2025 12:30PM
Dec 23, 2024 07:11AM
Nov 19, 2024 08:07AM
Nov 15, 2024 07:52AM
Sep 26, 2024 06:44AM
Sep 25, 2024 07:31AM InflaRx (IFRX) Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 European Academy of Dermatology and Venereology Congress
Sep 3, 2024 07:30AM
Aug 8, 2024 07:39AM
Jun 24, 2024 08:04AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All